🇺🇸 FDA
Pipeline program

RHB-204

RHB-204-01

Phase 3 small_molecule terminated

Quick answer

RHB-204 for Pulmonary Mycobacterium Avium Complex Infection is a Phase 3 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
RedHill Biopharma
Indication
Pulmonary Mycobacterium Avium Complex Infection
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials